NO20041819L - Diazacykloalakaner som oksytocinagonister - Google Patents

Diazacykloalakaner som oksytocinagonister

Info

Publication number
NO20041819L
NO20041819L NO20041819A NO20041819A NO20041819L NO 20041819 L NO20041819 L NO 20041819L NO 20041819 A NO20041819 A NO 20041819A NO 20041819 A NO20041819 A NO 20041819A NO 20041819 L NO20041819 L NO 20041819L
Authority
NO
Norway
Prior art keywords
diazacycloalacanes
oxytocin agonists
oxytocin
agonists
Prior art date
Application number
NO20041819A
Other languages
English (en)
Inventor
Gary Robert William Pitt
Peter Jeremy Hudson
David Philip Rooker
Andrzej Roman Batt
Celine Marguerite Simon Heeney
Michael Bryan Roe
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20041819L publication Critical patent/NO20041819L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20041819A 2001-08-16 2004-02-02 Diazacykloalakaner som oksytocinagonister NO20041819L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120051.8A GB0120051D0 (en) 2001-08-16 2001-08-16 Oxytocin agonists
PCT/GB2002/003593 WO2003016316A1 (en) 2001-08-16 2002-08-06 Diazacycloalkanes as oxytocin agonists

Publications (1)

Publication Number Publication Date
NO20041819L true NO20041819L (no) 2004-05-14

Family

ID=9920554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041819A NO20041819L (no) 2001-08-16 2004-02-02 Diazacykloalakaner som oksytocinagonister

Country Status (18)

Country Link
US (1) US20050032777A1 (no)
EP (1) EP1421087A1 (no)
JP (1) JP2005501858A (no)
KR (1) KR20040023728A (no)
CN (1) CN1285594C (no)
AR (1) AR042591A1 (no)
CA (1) CA2453962A1 (no)
GB (1) GB0120051D0 (no)
HK (1) HK1071132A1 (no)
IL (1) IL159821A0 (no)
MX (1) MXPA04001447A (no)
NO (1) NO20041819L (no)
NZ (1) NZ530587A (no)
PL (1) PL367543A1 (no)
RU (2) RU2311417C2 (no)
UY (1) UY27413A1 (no)
WO (1) WO2003016316A1 (no)
ZA (1) ZA200400272B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1449844A1 (en) 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
WO2005000826A1 (en) * 2003-06-23 2005-01-06 Cv Therapeutics, Inc. Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
EP1512687A1 (en) * 2003-09-05 2005-03-09 Ferring B.V. Piperazines as oxytocin agonists
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
WO2007050353A2 (en) * 2005-10-24 2007-05-03 Wyeth Tricyclic compounds useful as oxytocin receptor agonists
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds
GB201004677D0 (en) 2010-03-19 2010-05-05 Vantia Ltd New salt
CA2799733A1 (en) 2010-05-18 2011-11-24 Universite De Geneve New uses of oxytocin-like molecules and related methods
WO2011147889A1 (en) 2010-05-25 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
CN110248944A (zh) * 2016-12-12 2019-09-17 悉尼大学 非肽催产素受体激动剂
CN113429379A (zh) * 2021-06-28 2021-09-24 江苏法安德医药科技有限公司 一种lh-1801中间体及其制备方法和应用
CN116120261B (zh) * 2022-11-30 2024-01-23 浙大宁波理工学院 一种3-[（4-磺胺哌嗪-1-基）甲基]苯甲酸类化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW249201B (no) * 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
AR011913A1 (es) * 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
JPH111456A (ja) * 1997-06-13 1999-01-06 Otsuka Pharmaceut Co Ltd アミド誘導体
US5968938A (en) * 1997-06-18 1999-10-19 Merck & Co., Inc. Piperazine oxytocin receptor antagonists
GB2326639A (en) * 1997-06-18 1998-12-30 Merck & Co Inc Piperazine Oxytocin Receptor Antagonists

Also Published As

Publication number Publication date
CN1543467A (zh) 2004-11-03
EP1421087A1 (en) 2004-05-26
RU2007121219A (ru) 2008-12-20
GB0120051D0 (en) 2001-10-10
CA2453962A1 (en) 2003-02-27
ZA200400272B (en) 2004-11-18
AR042591A1 (es) 2005-06-29
RU2311417C2 (ru) 2007-11-27
WO2003016316A8 (en) 2003-10-02
HK1071132A1 (en) 2005-07-08
IL159821A0 (en) 2004-06-20
KR20040023728A (ko) 2004-03-18
WO2003016316A1 (en) 2003-02-27
UY27413A1 (es) 2003-02-28
CN1285594C (zh) 2006-11-22
NZ530587A (en) 2004-12-24
MXPA04001447A (es) 2004-07-08
RU2004101060A (ru) 2005-06-27
US20050032777A1 (en) 2005-02-10
JP2005501858A (ja) 2005-01-20
PL367543A1 (en) 2005-02-21

Similar Documents

Publication Publication Date Title
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NO20035775L (no) 3-fluor-pyrrolidiner som anti-diabetesmidler
IS7016A (is) Ný 4-anilínókínólín-3-karboxamíð
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
IS6971A (is) Ný efnasambönd
NO20030929L (no) Guanidinobenzamider som MC4-R agonister
HK1071132A1 (en) Diazycycloalkanes as oxytocin agonists
DK1429607T3 (da) Delta-1-pyrroliner som pesticider
DE60235536D1 (de) Sulfonamidderivate
NO20033234D0 (no) Carotenoider som hypertensive midler
FI20011048A (fi) Tilajärjestely
NO20041066L (no) Hydroksyeikosensyre-analoger
FI20010226A0 (fi) Kirves
NO20031239L (no) 1-amino-alkylsykloheksaner som trypanocidale midler
SE0100199D0 (sv) New formulation
DE60224192D1 (de) Antihaemorrhagische, betain-enthaltende zusammenseuzungen
SE0101660D0 (sv) New compounds
SE0101958D0 (sv) New compounds
SE0101659D0 (sv) New compounds
SE0102386D0 (sv) New compounds
SE0104342D0 (sv) New compounds
SE0104366D0 (sv) New compounds
SE0100272D0 (sv) New compounds
SE0103437D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application